Glucocorticoid_NN
resistance_NN
in_IN
chronic_JJ
asthma_NN
._.

Glucocorticoid_NN
pharmacokinetics_NNS
,_,
glucocorticoid_NN
receptor_NN
characteristics_NNS
,_,
and_CC
inhibition_NN
of_IN
peripheral_JJ
blood_NN
T_NN
cell_NN
proliferation_NN
by_IN
glucocorticoids_NNS
in_FW
vitro_FW
._.

A_DT
total_NN
of_IN
37_CD
chronic_JJ
,_,
severe_JJ
,_,
nonsmoking_JJ
asthmatic_JJ
patients_NNS
with_IN
documented_VBN
reversible_JJ
airways_NNS
obstruction_NN
were_VBD
classified_VBN
as_IN
glucocorticoid-sensitive_JJ
or_CC
-_JJ
resistant_JJ
on_IN
the_DT
basis_NN
of_IN
changes_NNS
in_IN
FEV1_NN
,_,
FVC_NN
,_,
and_CC
peak_NN
expiratory_JJ
flow_NN
-LRB-_-LRB-
PEF_NN
-RRB-_-RRB-
after_IN
oral_JJ
prednisolone_NN
._.

The_DT
resistant_JJ
patients_NNS
showed_VBD
no_DT
significant_JJ
improvements_NNS
in_IN
airflow_NN
limitation_NN
._.

Phytohemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
-_:
induced_JJ
proliferation_NN
of_IN
peripheral_JJ
blood_NN
T_NN
lymphocytes_NNS
from_IN
the_DT
sensitive_JJ
but_CC
not_RB
the_DT
resistant_JJ
asthmatic_JJ
patients_NNS
was_VBD
significantly_RB
-LRB-_-LRB-
p_NN
less_JJR
than_IN
0.01_CD
-RRB-_-RRB-
inhibited_VBN
by_IN
dexamethasone_NN
-LRB-_-LRB-
10_CD
-LRB-_-LRB-
-7_CD
-RRB-_-RRB-
mol\/L_NN
-RRB-_-RRB-
,_,
reflecting_VBG
a_DT
shift_NN
of_IN
the_DT
dose-response_JJ
curve_NN
._.

When_WRB
all_PDT
the_DT
asthmatic_JJ
patients_NNS
were_VBD
analyzed_VBN
together_RB
,_,
there_EX
was_VBD
a_DT
significant_JJ
correlation_NN
between_IN
the_DT
degree_NN
of_IN
sensitivity_NN
of_IN
T_NN
cells_NNS
to_TO
dexamethasone_NN
and_CC
the_DT
clinical_JJ
responsiveness_NN
to_TO
prednisolone_NN
-LRB-_-LRB-
p_NN
less_JJR
than_IN
0.01_CD
-RRB-_-RRB-
._.

No_DT
differences_NNS
were_VBD
observed_VBN
between_IN
six_CD
of_IN
the_DT
sensitive_JJ
and_CC
resistant_JJ
patients_NNS
in_IN
the_DT
clearance_NN
of_IN
plasma_NN
prednisolone_NN
derived_VBN
from_IN
orally_RB
administered_VBN
prednisone_NN
._.

Peripheral_JJ
blood_NN
mononuclear_JJ
cell_NN
glucocorticoid_NN
receptors_NNS
were_VBD
also_RB
characterized_VBN
in_IN
five_CD
sensitive_JJ
and_CC
seven_CD
resistant_JJ
patients_NNS
._.

The_DT
numbers_NNS
and_CC
binding_NN
affinities_NNS
of_IN
these_DT
receptors_NNS
could_MD
not_RB
account_VB
for_IN
the_DT
observed_VBN
difference_NN
in_IN
the_DT
susceptibility_NN
of_IN
these_DT
cells_NNS
to_TO
functional_JJ
inhibition_NN
by_IN
dexamethasone_NN
in_FW
vitro_FW
._.

These_DT
results_NNS
suggest_VBP
that_IN
clinical_JJ
glucocorticoid_NN
resistance_NN
in_IN
chronic_JJ
asthma_NN
does_VBZ
not_RB
reflect_VB
abnormal_JJ
glucocorticoid_NN
clearance_NN
but_CC
may_MD
be_VB
due_JJ
at_IN
least_JJS
partly_RB
to_TO
a_DT
relative_JJ
insensitivity_NN
of_IN
T_NN
lymphocytes_NNS
to_TO
glucocorticoids_NNS
._.

This_DT
lack_NN
of_IN
sensitivity_NN
is_VBZ
unexplained_JJ
but_CC
is_VBZ
not_RB
attributable_JJ
to_TO
abnormalities_NNS
of_IN
cellular_JJ
glucocorticoid_NN
receptors_NNS
._.

